Meta is set to start manufacturing its in-house AI chip (codenamed Iris) from September and target 14 GW of AI data-center capacity by next year, with Iris central to its MTIA training/inference accelerators—supporting Broadcom’s custom AI chip roadmap. Meta’s 2026 capex guidance was raised to $125B–$145B from $115B–$135B, a potential demand tailwind for Broadcom’s AI silicon business. The article highlights Broadcom’s recent momentum (Q2 EPS +54% YoY; Q3 revenue guidance $29.4B vs. implied 84% YoY growth) and argues that the stock could be on track for upside to ~$775 (~107%) if earnings expand to $25.85 by fiscal 2028.
The important read-through is not that one hyperscaler is buying chips, but that a large share-of-wallet shift toward custom silicon is becoming more credible at scale. That favors AVGO because the economics of these programs are front-loaded: once a design is embedded in a customer’s training/inference stack, revenue visibility extends for years and gross margin leverage usually follows the deployment curve with a lag. The second-order winner is the broader custom-ASIC ecosystem; the loser is incremental merchant-GPU intensity, but that is a slow bleed rather than an immediate substitution shock.
Near term, the market will probably trade this as a valuation story before it trades it as a fundamentals story. AVGO can re-rate if investors start underwriting a longer runway of AI dollar content per deployment, but the catalyst path is lumpy: the key checkpoints are Meta’s next capex print, any commentary on yield/ramp timing, and whether AVGO shows an acceleration in custom-silicon revenue mix in the next two quarters. If those slip, the stock likely gives back the optimism quickly because the multiple already assumes sustained execution.
Contrarianly, consensus may be overestimating how linear these ramps are. Custom chips rarely scale cleanly from pilot to full fleet; any issue in packaging, thermals, or software integration can defer revenue while still consuming engineering spend, which would pressure margins before it helps EPS. For META, the risk is that capex intensity rises faster than monetization, making this a longer-duration story than the headline suggests; for AVGO, the best risk/reward is to own the name on weakness rather than chase strength after each hyperscaler announcement.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment